pharmaceuticals

Key highlights from Sun Pharma Q2 2022 earnings results

● Nov 2, 2021

Sun Pharmaceutical Industries (NSE: SUNPHARMA) reported its second-quarter 2022 earnings results today. The company reported consolidated revenue of ₹98.4 billion...

Cipla Ltd (CIPLA) Q2 FY22 Earnings Concall Transcript

● Nov 2, 2021

Cipla Limited (NSE: CIPLA) Q2 FY22 Earnings Concall dated Oct. 26, 2021 Corporate Participants: Naveen Bansal — Director, Finance Kedar Upadhye...

Key highlights from Dr Reddy’s Q2 2022 earnings results

● Oct 29, 2021

Dr Reddy’s Laboratories (NSE: DRREDDY) reported its second-quarter financial results for the period ended September 30, 2021. The company had...

How Cipla performed in Q2 2022

● Oct 26, 2021

The pharma giant Cipla (NSE: CIPL) reported its second-quarter 20223 earnings results on Tuesday after market hours. The total revenue...

IPO Alert: What to expect when Emcure Pharma hits public markets

● Sep 3, 2021

India’s domestic pharmaceutical market is estimated at $42 billion in 2021. It is likely to reach $65 billion by 2024...

Ami Organics files IPO worth ₹300 crore

● Jul 6, 2021

The pharmaceutical market in India was valued at $59 billion in 2020 and supplies over 50% globally for various vaccines....

Alembic Pharmaceuticals Ltd. (APLLTD) Q4 FY21 Earnings Concall

● May 4, 2021

Alembic Pharmaceuticals Ltd. (NSE:APLLTD) Q4 FY21 Earnings Concall dated May 04, 2021

Cipla Ltd (CIPLA) Q3 FY21 Earnings Concall Transcript

● Jan 29, 2021

Cipla Limited  (NSE:CIPLA) Q3 FY21 earnings concall dated Jan. 29, 2021. Corporate Participants: Kumar Gaurav — Vice President, Kotak Institutional...

Alembic Pharmaceuticals Limited (APLLTD) Q3 FY21 Earnings Concall Transcript

● Jan 19, 2021

Alembic Pharmaceuticals Limited  (NSE:APLLTD) Q3 FY21 earnings concall dated Jan. 19, 2021. Corporate Participants: R. K. Baheti — Director –...